Pinnacle Wealth Planning Services’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-994
Closed -$14.4K 2781
2026
Q1
$14.4K Hold
994
﹤0.01% 1854
2025
Q4
$14.2K Buy
+994
New +$9.77K ﹤0.01% 1872
2021
Q1
Sell
-4,009
Closed -$93K 936
2020
Q4
$93K Buy
+4,009
New +$82K 0.02% 503

Other funds holding FOLD

Pinnacle Wealth Planning Services's FOLD Position: Q2 2026 in Review

Pinnacle Wealth Planning Services sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 994 shares — an estimated $14.4K sold.

Pinnacle Wealth Planning Services first reported a position in FOLD in Q4 2020 and held it in 3 quarters. The position peaked at $93K in Q4 2020. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Pinnacle Wealth Planning Services reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Pinnacle Wealth Planning Services sold 994 Amicus Therapeutics shares in Q2 2026, an estimated $14.4K.
  • Pinnacle Wealth Planning Services first reported a position in Amicus Therapeutics in Q4 2020 and held it in 3 quarters.
  • Pinnacle Wealth Planning Services's Amicus Therapeutics position peaked at $93K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.